Navigation Links
Maquet Medical Systems USA, A Getinge Group Company Announces Partnership with BIOTRONIK to Distribute Endovascular Medical Devices in United States
Date:2/3/2016

WAYNE, N.J., Feb. 3, 2016 /PRNewswire/ -- Maquet Medical Systems USA, a Getinge Group Company announced today that it has entered into a partnership with BIOTRONIK, a Berlin, Germany-based manufacturer of cardiovascular and endovascular medical devices, to distribute BIOTRONIK's peripheral vascular devices in the United States.

Under the terms of the agreement, Maquet will distribute a range of BIOTRONIK products used to treat peripheral artery disease (PAD). These include the Astron iliac self-expanding stent, which was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of iliac artery disease, the Passeo percutaneous transluminal angioplasty (PTA) balloon family, and the Fortress family of reinforced sheaths. Maquet will begin distributing BIOTRONIK's products during the first quarter of 2016.

"Peripheral artery disease is a serious condition that can lead to amputations. Because the global prevalence of this disease is increasing, the need for innovative endovascular devices with which to treat patients is growing," said Raoul Quintero, President of the Americas at Getinge Group. "Partnering with BIOTRONIK allows us to enhance our current product offerings and expand our existing portfolio of vascular grafts and patches. With the addition of BIOTRONIK's innovative product line, we can now provide PAD patients in the United States and the vascular surgeons who treat them with a complete range of technically-advanced, high-quality endovascular devices."

"We are pleased to partner with Maquet to make our proven vascular intervention products available to patients and physicians in the United States," said Marlou Janssen, President of BIOTRONIK, Inc. "Maquet is a highly-regarded medical device company that has a wealth of experience marketing innovative technology to clinicians. This partnership will ensure that our peripheral vascular product line, including our newly approved Astron iliac stent, will now benefit patients in the United States."

About Maquet's Vascular Device Portfolio
Maquet's vascular device portfolio includes a full line of vascular grafts and patches, which have been implanted in millions of patients worldwide. This extensive portfolio includes the FUSION BIOLINE Vascular Graft, FLIXENE, and the HEMASHIELD family of vascular grafts and patches.  Maquet's vascular products will be complemented by BIOTRONIK's product line, which includes the Astron stent, a proven option for treating atherosclerotic disease of the common or external iliac arteries, which supply blood to the pelvic organs and much of the lower limbs. Atherosclerotic disease of the iliac arteries can greatly impact a patient's overall quality of life, limiting walking ability and leading to chronic pain and morbidity. Endovascular interventions, including angioplasty and stenting, have become the first-line approach for the treatment of patients with simple and complex peripheral atherosclerotic lesions, including challenging-to-access iliac lesions. In 2014, an estimated 176,800 patients in the United States received an iliac stent, and that number is expected to grow annually. Results of a 12-month study of Astron demonstrated a Major Adverse Event (MAE) rate of just 2.1 percent compared with the pre-specified performance goal of 15 percent. Astron's 12-month target lesion revascularization rate was 1.4 percent.

About Getinge Group
Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers – improving the every-day life for people, today and tomorrow.

About BIOTRONIK
One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products.

Logo - http://photos.prnewswire.com/prnh/20160115/322743LOGO

 


'/>"/>
SOURCE Maquet Medical Systems USA
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. MAQUET Medical Systems USA Launches LED Concealed Lighting System For Labor, Delivery And Recovery Room
2. Richard Wolf USA And MAQUET Launch OR Integration Sales Partnership
3. Maquet Medical Systems USA to Exclusively Distribute Flight Medicals Flight 60 Respiratory Ventilators
4. Maquet Announces Peer-Reviewed Publication Confirming Intraaortic Balloon Pumps as the Clinically and Economically Cost-Effective First Line Choice for High-Risk PCI Patients
5. Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating
6. Maquet Celebrates Major Milestone with Over Two Million Procedures Performed Using its Minimally Invasive Endoscopic Vessel Harvesting System
7. Maquet Medical Systems USA Announces Exclusive U.S. Distribution Agreement With ReFlow Medical, Inc. To Expand Cardiac Solutions
8. Vasomedical Announces Financial Results for the First Quarter of 2013
9. CCS Medical Moves Forward as Medicare Winner
10. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
11. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/15/2020)... (PRWEB) , ... March 13, 2020 , ... ... the news, and the World Health Organization (WHO) recently declared the outbreak a ... with the virus, which was first detected in Wuhan, China in December 2019. ...
(Date:3/15/2020)... ... ... COVID-19 is going to affect every business and every person and it will have ... (COVID-19) virus pandemic, MSPs should consider themselves as first responders in helping clients mitigate ... like ransomware, the MSP is in a unique position to help address through:, ...
(Date:3/15/2020)... ... March 14, 2020 , ... The ... not only of infection, but increased isolation. , “Senior living communities like Aldersgate ... right message gets to the right person at the right time,” says Kyle ...
Breaking Medicine Technology:
(Date:3/28/2020)... ... March 27, 2020 , ... ... public from the spread of the coronavirus. Operating under the designation as an ... with infrastructure renewal and environmental protection projects in the downstate New York region. ...
(Date:3/28/2020)... ... March 27, 2020 , ... Ahead of National ... edition of “The Fertility Journey.” This campaign will serve as a guide, showcasing ... maternal health options. , One in 6 couples experiences trouble with fertility. ...
(Date:3/28/2020)... Ky. (PRWEB) , ... March 28, 2020 , ... ... El Paso Physical Therapy Services (EPPTS), a physical therapist-owned rehabilitation company since 1985 ... in El Paso, TX. , “Since we started more than 30 years ago, ...
(Date:3/27/2020)... ... March 27, 2020 , ... On March 27th, 2020, Talos Health Solutions ... asthma, their families and caregivers living in the US. This free online conference will ... 30, 2020, and will focus on asthma symptoms, the different kinds of asthma, treatment ...
(Date:3/27/2020)... ... March 27, 2020 , ... During a time of global distress and concern about the ... to the UNITE HERE Education and Support Fund in an effort to assist ... UNITE HERE represents 300,000 working people in the food service , hotel ...
Breaking Medicine News(10 mins):